Mimedx (MDXG) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Mimedx (MDXG) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -347.04% |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 1,378.45% |
| 10 | Mimedx | 647.00 Mn | 487.23 Mn | 41.62 Mn | -396.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -396.12% |
| Dec 31, 2025 | 281.84% |
| Sep 30, 2025 | 377.28% |
| Jun 30, 2025 | 44.29% |
| Mar 31, 2025 | 142.51% |
| Dec 31, 2024 | -200.69% |
| Sep 30, 2024 | -3.83% |
| Jun 30, 2024 | 88.65% |
| Mar 31, 2024 | 2,474.19% |
| Dec 31, 2023 | -186.88% |
| Sep 30, 2023 | 207.17% |
| Jun 30, 2023 | 177.95% |
| Mar 31, 2023 | 97.12% |
| Dec 31, 2022 | 413.11% |
| Sep 30, 2022 | -505.06% |
| Jun 30, 2022 | -747.26% |
| Mar 31, 2022 | -29.91% |
| Dec 31, 2021 | -97.90% |
| Sep 30, 2021 | -128.37% |
| Jun 30, 2021 | 64.79% |